Search
for
Sort by
Research 271–300 of 1000+
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Drug-induced hair colour changes
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Prospective Case Series of Cutaneous Adverse Effects Associated With Dabrafenib and Trametinib
- Organizadores e cortadores de comprimidos: riscos e restrições ao uso
- TOC
- Cutaneous manifestations of COVID-19 and vaccines for its prevention: a review of the existing literature
- Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Photosensitivity reaction induced by finasteride
- Semaglutide and the Skin: An Overview of Current Evidence
- Festschrift in honor of the 65th birthday of Dr. Howard I. Maibach
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Disease modifying agent related skin reactions in multiple sclerosis: prevention, assessment, and management
- Chemotherapy-related adverse effects with anthracycline and taxane-containing regimens in patients with localized Breast cancer: a descriptive study
- Adverse cutaneous effects of psychotropic medications
- Successful rapid subcutaneous desensitization to anakinra in a case of delayed‐type hypersensitivity reaction
- DERMATOLOGICAL AND SYSTEMIC REACTIONS TO HAIR DYES: CURRENT EVIDENCE AND MANAGEMENT
- Trans-Epidermal Elimination Due to Insulin Formulation: Report of a Rare Adverse Effect
- Hair Care Cosmetics Regulation in Different Countries – A Comparative Study
- Nurses' Drug Alert
- PC039: Adverse effects at the level of marginal periodontium secondary to Finasteride administration
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Semaglutide-Induced Atypical Pustular Drug Eruption: A Case Report
- Investigating tralokinumab-related adverse events in treating atopic dermatitis: insights from the FAERS database
- Androgenetic alopecia; drug safety and therapeutic strategies
- Fluoroquinolone-induced serious, persistent, multisymptom adverse effects
- Signal Mining for Non-Bleeding Adverse Event in Novel Oral Anticoagulants: A Pharmacovigilance Study Based on the FAERS Database
- Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment